Company Analysis
Sign in

Ernexa Therapeutics Inc. (ERNA)

Nasdaq: ERNA · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 1994
Full chart Alerts Compare
Grade3.0
◀ Past 1.2● Present 1.7▶ Future 5.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 13, 2026Mar 12, 2025Mar 14, 2024Mar 20, 2023Apr 15, 2022Mar 11, 2021Mar 19, 2020Mar 22, 2019Mar 9, 2018Mar 9, 2017
Revenue·582680·5,80019,80623,33521,27422,312
For lenders
Interest expense on deposits and borrowings·1,400300·······
Cost of revenue·962360······
Gross profit·486-1680······
Research and development4,1564,6045,92010,39212,7053,9512672139·
Selling, general and administrative·····8,09113,17514,463r15,58716,458
General and administrative5,16313,13214,58716,83514,7243,297····
Total operating expenses9,31916,16020,96733,217113,732r7,248r21,56823,13222,67624,590
Operating income-9,319-15,674-21,135-33,217-113,732r-7,248r-1,762203-1,402-2,278
Interest expense221741760·118236296425517
Interest and investment income832491380······
Interest income (expense), net-27-6,752-614·······
Other income (expense), net21570-334-1,141r899-43r-258-526391r-31
Total non-operating income (expense)-4,810-28,835-5368,683-8,749-43··391-607
Income before income taxes-14,129-44,509-21,671-24,534-122,481r-7,291r-2,020-323-1,011-2,885
Income tax expense-4530-34564r0r27-646638
Net income-14,084-44,539-21,668-24,579-122,545r-7,291r-2,047-259-1,077-2,923
Preferred dividends······1616··
Net income to common shareholders-14,100-44,555-21,684-24,595-122,561r-7,291r-2,063-275-1,093·
Earnings per share, basic-2.24-48.96r-61.20b-120.90b-849.15rb-123.00rb····
Earnings per share, diluted-2.24-48.96r-61.20b-120.90b-849.15rb-123.00rb····
Earnings per share, basic and diluted·····-453.00b-216.00b-30.00b-135.00rb-462.00b
Weighted average shares, basic6,307,000910,000r354,267b203,400b144,333rb58,627b····
Weighted average shares, diluted6,307,000910,000r354,267b203,400b144,333rb58,627b····
Weighted average shares, basic and diluted·····10b10b9rb8,140b6,343b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Interest expense on deposits and borrowings what it paid for the money it lendsus-gaap:InterestExpenseOperating
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ERNA · research, not advice